According to a new Sheba study, the Pfizer-BioNTech COVID-19 vaccine is highly effective: 98% saw a major increase in COVID-19 antibodies. Learn more.
Trial of the COVID-19 vaccine developed by the Israel Institute of Biological Research is set to move into Phase II within a few weeks.
Recent research conducted in Israel showed how the CRISPR-Cas9 gene editing system can be effective against metastatic cancer.
A recent partnership between Sheba and Toronto General aims to advance lung transplantation in Israel, revolutionizing how the procedure is performed.
Two more reasons to be proud of our Sheba family! Prof. Ella Mendelssohn, director at Sheba’s Virology Lab, was the first scientist to receive a sample of the coronavirus in Israel.
Proper hand hygiene is a vital part of preventing the spread of COVID-19, and an Israeli company has redesigned the sink to help people get squeaky clean.
Hospitals in Israel report a high number of patients suffering from chronic COVID. In this condition, various serious symptoms appear after recovery, and they can last a long time.
To keep schools open for safe learning, an inventive pilot program for rapid corona testing was designed by Sheba and launched this week.
medical tourism division
Medical Tourism at Sheba
CONTACT SHEBA MEDICAL CENTER
The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician.
Additionally, you are browsing the official – and only – website of Sheba Medical Center and not an agent or affiliate website.